StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock in […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price target on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company in […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price target on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock in a […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price target on shares of Aeterna Zentaris in a report […]